Biosimilars for Cancer Emerge as Patents on Widely Used Biological Drugs Expire

As the patents on some widely used drugs to treat cancer expire in the coming years, biosimilar drugs are being developed for the treatment of patients with cancer. Are biosimilars effective and will they expand treatment options for patients?

Cancer Currents: An NCI Cancer Research Blog